Sirnaomics Ltd. (HKG:2257)
Hong Kong · Delayed Price · Currency is HKD 4.000
-0.330 (-7.62%)
Aug 27, 2026, 4:08 PM HKT
Sirnaomics Market Cap
Sirnaomics has a market cap or net worth of 435.6 million as of August 27, 2026. Its market cap has decreased by -58.25% in one year.
Market Cap
435.60M
Enterprise Value
289.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.00
ChartMarket Cap Chart
Since December 30, 2021, Sirnaomics's market cap has decreased from 6.86B to 435.60M, a decrease of -93.65%. That is a compound annual growth rate of -44.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 435.60M | -46.62% |
| Dec 31, 2025 | 816.08M | 126.04% |
| Dec 31, 2024 | 361.03M | -88.38% |
| Dec 29, 2023 | 3.11B | -38.75% |
| Dec 30, 2022 | 5.07B | -36.82% |
| Dec 31, 2021 | 8.03B | 17.07% |
| Dec 30, 2021 | 6.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 866.63M |
| 3D Medicines | 773.42M |
| JW (Cayman) Therapeutics Co. | 748.88M |
| Brii Biosciences | 729.03M |
| B&K Corporation | 697.12M |
| Cutia Therapeutics | 679.50M |
| Wuhan YZY Biopharma | 639.70M |
| Shanghai Bio-heart Biological Technology | 507.52M |